| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |